Filing Details
- Accession Number:
- 0001209191-18-061104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-06 08:05:23
- Reporting Period:
- 2018-12-03
- Accepted Time:
- 2018-12-06 08:05:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1607965 | A. Andrew Hindman | 420 Saw Mill River Road Ardsley NY 10502 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-12-03 | 753 | $20.56 | 5,171 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.